Altre lingue Baotou Dongbao Bio-Tech Co.,Ltd

Azioni

300239

CNE100001583

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 19/06/2024			Variaz. 5gg	Var. 1 gen.
4,98 ^CNY	+0,20%		+1,43%	-20,06%

15/05	Baotou Dongbao Bio-Tech Co.,Ltd approva le nomine dei dirigenti	CI
23/04	Baotou Dongbao Bio-Tech Co.,Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Baotou Dongbao Bio-Tech Co.,Ltd Announces 2023 Final Cash Distribution Plan on A Shares, Payable on 31 May 2024	24/05
Baotou Dongbao Bio-Tech Co.,Ltd Approves Management Appointments	15/05
Baotou Dongbao Bio-Tech Co.,Ltd Approves Final Cash Dividend for the Year 2023	15/05
Baotou Dongbao Bio-Tech Co.,Ltd Proposes Final Cash for the Year 2023	24/04
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	23/04
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Baotou Dongbao Bio-Tech Raises 455 Million Yuan From Bond Sale	04/08/23
Baotou Dongbao Bio-Tech Co.,Ltd Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 19 May 2023	11/05/23
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Baotou Dongbao Bio-Tech Co.,Ltd Approves Cash Dividend for the Year 2022	17/04/23
Baotou Dongbao Bio-Tech Co.,Ltd Proposes Cash Dividend for 2022	22/03/23
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22
Qingdao Yiqing Biotechnology Co., Ltd. announced that it has received CNY 100.45 million in funding from Baotou Dongbao Bio-Tech Co.,Ltd, Qingdao Gon Technology Co., Ltd., Qingdao Deyu Biological Investment Partnership (limited partnership)	13/10/22
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22
Qingdao Yiqing Biotechnology Co., Ltd. announced that it expects to receive CNY 100.45 million in funding from Baotou Dongbao Bio-Tech Co.,Ltd, Qingdao Gon Technology Co., Ltd., Qingdao Deyu Biological Investment Partnership (limited partnership)	25/08/22
Baotou Dongbao Bio-Tech Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 10 June 2022	02/06/22
Baotou Dongbao Bio-Tech Co.,Ltd Approves Profit Distribution Plan for 2021	19/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Baotou Dongbao Bio-Tech Co.,Ltd

Azioni

300239

CNE100001583

Altre lingue

Filtri